Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Models, Immunological"" wg kryterium: Temat


Tytuł :
Overcoming COVID-19 vaccination resistance when alternative policies affect the dynamics of conformism, social norms, and crowding out.
Autorzy :
Schmelz K; Department of Economics, University of Konstanz, 78457 Konstanz, Germany; .; Thurgau Institute of Economics (TWI), 8280 Kreuzlingen, Switzerland.
Bowles S; Behavioral Sciences Program Santa Fe Institute, Santa Fe, NM 87501.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Jun 22; Vol. 118 (25).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Crowding*
Social Conformity*
Social Norms*
Vaccination*
COVID-19/*immunology
COVID-19 Vaccines/*immunology
Health Policy ; Humans ; Models, Immunological ; Motivation
Czasopismo naukowe
Tytuł :
Neutralizing monoclonal antibodies for treatment of COVID-19.
Autorzy :
Taylor PC; Botnar Research Centre, University of Oxford, Oxford, UK. .
Adams AC; Eli Lilly and Company, Indianapolis, IN, USA.
Hufford MM; Eli Lilly and Company, Indianapolis, IN, USA.
de la Torre I; Eli Lilly and Company, Indianapolis, IN, USA.
Winthrop K; Oregon Health & Science University, Portland, OR, USA.
Gottlieb RL; Baylor University Medical Center, Dallas, TX, USA.; Baylor Scott & White Research Institute, Dallas, TX, USA.
Pokaż więcej
Źródło :
Nature reviews. Immunology [Nat Rev Immunol] 2021 Jun; Vol. 21 (6), pp. 382-393. Date of Electronic Publication: 2021 Apr 19.
Typ publikacji :
Journal Article; Review
MeSH Terms :
SARS-CoV-2*/drug effects
SARS-CoV-2*/genetics
SARS-CoV-2*/immunology
Antibodies, Monoclonal/*therapeutic use
Antibodies, Neutralizing/*therapeutic use
Antibodies, Viral/*therapeutic use
COVID-19/*therapy
Antibodies, Monoclonal, Humanized/therapeutic use ; Antibody-Dependent Enhancement ; COVID-19/immunology ; COVID-19/virology ; Drug Development ; Drug Resistance, Viral/genetics ; Drug Resistance, Viral/immunology ; Humans ; Immunization, Passive/adverse effects ; Immunization, Passive/methods ; Models, Immunological ; Pandemics
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection.
Autorzy :
Cromer D; Kirby Institute, University of New South Wales, Sydney, Australia.
Juno JA; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Khoury D; Kirby Institute, University of New South Wales, Sydney, Australia.
Reynaldi A; Kirby Institute, University of New South Wales, Sydney, Australia.
Wheatley AK; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
Kent SJ; Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. .
Davenport MP; Kirby Institute, University of New South Wales, Sydney, Australia. .
Pokaż więcej
Źródło :
Nature reviews. Immunology [Nat Rev Immunol] 2021 Jun; Vol. 21 (6), pp. 395-404. Date of Electronic Publication: 2021 Apr 29.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
SARS-CoV-2*/genetics
SARS-CoV-2*/immunology
COVID-19/*immunology
COVID-19/*prevention & control
Pandemics/*prevention & control
Reinfection/*immunology
Reinfection/*prevention & control
Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; Antigenic Variation ; B-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; COVID-19/virology ; COVID-19 Vaccines/immunology ; COVID-19 Vaccines/pharmacology ; Humans ; Immunologic Memory ; Models, Immunological ; Time Factors
SCR Organism :
SARS-CoV-2 variants
Czasopismo naukowe
Tytuł :
Atopic endotypes as a modulating factor for SARS-CoV-2 infection: mechanisms and implications.
Autorzy :
Huntley KS; Dr Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, Florida.
Fine L; Dr Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Fort Lauderdale, Florida.
Bernstein JA; University of Cincinnati College of Medicine, Department of Internal Medicine, Division of Immunology/Allergy Section, Cincinnati, Ohio, USA.
Pokaż więcej
Źródło :
Current opinion in allergy and clinical immunology [Curr Opin Allergy Clin Immunol] 2021 Jun 01; Vol. 21 (3), pp. 252-260.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Models, Immunological*
Virus Internalization*
Asthma/*immunology
COVID-19/*immunology
SARS-CoV-2/*immunology
Angiotensin-Converting Enzyme 2/immunology ; Humans ; Risk Factors ; Serine Endopeptidases/immunology
Czasopismo naukowe
Tytuł :
Dynamic causal modelling of immune heterogeneity.
Autorzy :
Parr T; Wellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, London, UK. .
Bhat A; Wellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, London, UK.
Zeidman P; Wellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, London, UK.
Goel A; Royal Stoke University Hospital, Stoke-on-Trent, UK.
Billig AJ; UCL Ear Institute, University College London, London, UK.
Moran R; Centre for Neuroimaging Science, Department of Neuroimaging, IoPPN, King's College London, London, UK.
Friston KJ; Wellcome Centre for Human Neuroimaging, Queen Square Institute of Neurology, London, UK.
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2021 May 31; Vol. 11 (1), pp. 11400. Date of Electronic Publication: 2021 May 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Viral/*immunology
B-Lymphocytes/*immunology
COVID-19/*immunology
SARS-CoV-2/*immunology
T-Lymphocytes/*immunology
Antibody Formation ; Bayes Theorem ; Computer Simulation ; Cross Reactions/immunology ; Humans ; Models, Immunological ; SARS-CoV-2/pathogenicity ; Viral Load
Czasopismo naukowe
Tytuł :
Compartmental Model Suggests Importance of Innate Immune Response to COVID-19 Infection in Rhesus Macaques.
Autorzy :
Mochan E; Department of Analytical, Physical, and Social Sciences, Carlow University, 3333 Fifth Ave, Pittsburgh, PA, 15213, USA. .
Sego TJ; Department of Intelligent Systems Engineering, Indiana University, Bloomington, IN, 47408, USA.
Gaona L; Department of Analytical, Physical, and Social Sciences, Carlow University, 3333 Fifth Ave, Pittsburgh, PA, 15213, USA.
Rial E; Department of Mathematics, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
Ermentrout GB; Department of Mathematics, University of Pittsburgh, Pittsburgh, PA, 15213, USA.
Pokaż więcej
Źródło :
Bulletin of mathematical biology [Bull Math Biol] 2021 May 26; Vol. 83 (7), pp. 79. Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Immunity, Innate*
Models, Immunological*
SARS-CoV-2*/immunology
COVID-19/*immunology
Macaca mulatta/*immunology
Adaptive Immunity ; Aging/immunology ; Animals ; Anti-Inflammatory Agents/administration & dosage ; Anti-Inflammatory Agents/pharmacology ; Antiviral Agents/administration & dosage ; Antiviral Agents/pharmacology ; COVID-19/drug therapy ; COVID-19/epidemiology ; Computer Simulation ; Disease Models, Animal ; Dose-Response Relationship, Drug ; Host Microbial Interactions/drug effects ; Host Microbial Interactions/immunology ; Humans ; Mathematical Concepts ; Pandemics ; Respiratory System/immunology ; Respiratory System/virology ; Viral Load/immunology
Czasopismo naukowe
Tytuł :
TNF controls a speed-accuracy tradeoff in the cell death decision to restrict viral spread.
Autorzy :
Oyler-Yaniv J; Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, CA, USA.
Oyler-Yaniv A; Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, CA, USA.
Maltz E; Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, CA, USA.
Wollman R; Institute for Quantitative and Computational Biosciences, University of California, Los Angeles, CA, USA. .; Department of Integrative Biology and Physiology, University of California UCLA, Los Angeles, CA, USA. .; Department of Chemistry and Biochemistry, University of California UCLA, Los Angeles, CA, USA. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2021 May 20; Vol. 12 (1), pp. 2992. Date of Electronic Publication: 2021 May 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Apoptosis/*immunology
Herpes Simplex/*immunology
Herpesvirus 1, Human/*immunology
Macrophages/*immunology
Tumor Necrosis Factor-alpha/*metabolism
Animals ; Cornea/immunology ; Cornea/virology ; Disease Models, Animal ; Female ; Herpes Simplex/virology ; Host-Pathogen Interactions/immunology ; Humans ; Intravital Microscopy ; Macrophages/metabolism ; Male ; Mice ; Mice, Knockout ; Models, Immunological ; NIH 3T3 Cells ; Organ Culture Techniques ; Primary Cell Culture ; Time-Lapse Imaging ; Tumor Necrosis Factor-alpha/genetics
Czasopismo naukowe
Tytuł :
Dopaminergic Receptor Targeting in Multiple Sclerosis: Is There Therapeutic Potential?
Autorzy :
Melnikov M; Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.; Department of Neuroimmunology, Federal Center of Brain Research and Neurotechnology of the Federal Medical-Biological Agency of Russia, 117997 Moscow, Russia.; Laboratory of Clinical Immunology, National Research Center Institute of Immunology of the Federal Medical-Biological Agency of Russia, 115522 Moscow, Russia.
Pashenkov M; Laboratory of Clinical Immunology, National Research Center Institute of Immunology of the Federal Medical-Biological Agency of Russia, 115522 Moscow, Russia.
Boyko A; Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University, 117997 Moscow, Russia.; Department of Neuroimmunology, Federal Center of Brain Research and Neurotechnology of the Federal Medical-Biological Agency of Russia, 117997 Moscow, Russia.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 May 18; Vol. 22 (10). Date of Electronic Publication: 2021 May 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Dopamine/*immunology
Multiple Sclerosis/*drug therapy
Receptors, Dopamine/*drug effects
Animals ; Dopamine/physiology ; Dopamine Agents/pharmacology ; Encephalomyelitis, Autoimmune, Experimental/drug therapy ; Encephalomyelitis, Autoimmune, Experimental/immunology ; Encephalomyelitis, Autoimmune, Experimental/physiopathology ; Humans ; Mice ; Models, Immunological ; Models, Neurological ; Multiple Sclerosis/immunology ; Multiple Sclerosis/physiopathology ; Neuroimmunomodulation/drug effects ; Neuroimmunomodulation/immunology ; Neuroimmunomodulation/physiology ; Receptors, Dopamine/immunology ; Receptors, Dopamine/physiology ; Th17 Cells/drug effects ; Th17 Cells/immunology
Czasopismo naukowe
Tytuł :
Quantification of Cytokine Storms During Virus Infections.
Autorzy :
Yuan S; College of Resources, Sichuan Agricultural University, Chengdu, China.
Jiang SC; Chengdu KangHong Pharmaceutical Group Comp. Ltd., Chengdu, China.
Zhang ZW; College of Resources, Sichuan Agricultural University, Chengdu, China.
Fu YF; College of Resources, Sichuan Agricultural University, Chengdu, China.
Hu J; School of Medicine, Northwest University, Xi'an, China.
Li ZL; Department of Cardiovascular Surgery, Xijing Hospital, Medical University of the Air Force, Xi'an, China.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2021 May 17; Vol. 12, pp. 659419. Date of Electronic Publication: 2021 May 17 (Print Publication: 2021).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Models, Immunological*
Cytokine Release Syndrome/*immunology
Cytokines/*blood
Virus Diseases/*complications
Biomarkers/blood ; Biomarkers/metabolism ; Cytokine Release Syndrome/blood ; Cytokine Release Syndrome/diagnosis ; Cytokine Release Syndrome/virology ; Cytokines/immunology ; Cytokines/metabolism ; Humans ; Viral Load/immunology ; Virus Diseases/blood ; Virus Diseases/immunology ; Virus Diseases/virology
Czasopismo naukowe
Tytuł :
IL-6-based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts.
Autorzy :
Utrero-Rico A; Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Ruiz-Hornillos J; Allergy Unit, Hospital Infanta Elena, Valdemoro, Madrid, Spain; Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain; Faculty of Medicine, Universidad Francisco de Vitoria, Madrid, Spain.
González-Cuadrado C; Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.
Rita CG; Department of Immunology, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
Almoguera B; Department of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Minguez P; Department of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Herrero-González A; Data Analysis Department, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
Fernández-Ruiz M; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; Unit of Infectious Diseases, Hospital Universitario 12 de Octubre, Madrid, Spain.
Carretero O; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; Unit of Infectious Diseases, Hospital Universitario 12 de Octubre, Madrid, Spain.
Taracido-Fernández JC; Data Analysis Department, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
López-Rodriguez R; Department of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Corton M; Department of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Aguado JM; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; Unit of Infectious Diseases, Hospital Universitario 12 de Octubre, Madrid, Spain; Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
Villar LM; Department of Immunology, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
Ayuso-García C; Department of Genetics & Genomics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 28029, Madrid, Spain.
Paz-Artal E; Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.
Laguna-Goya R; Department of Immunology, Hospital Universitario 12 de Octubre, Madrid, Spain; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain. Electronic address: .
Pokaż więcej
Źródło :
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2021 May; Vol. 147 (5), pp. 1652-1661.e1. Date of Electronic Publication: 2021 Mar 01.
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study; Validation Study
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/immunology
COVID-19*/mortality
Models, Immunological*
Interleukin-6/*immunology
SARS-CoV-2/*immunology
Age Factors ; Aged ; Aged, 80 and over ; Europe/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Modeling of tumor response to macrophage and T lymphocyte interactions in the liver metastatic microenvironment.
Autorzy :
Curtis LT; Department of Bioengineering, University of Louisville, Lutz Hall 419, Louisville, KY, 40292, USA.
Sebens S; Institute for Experimental Cancer Research, Christian-Albrechts-University Kiel (CAU), Kiel, Germany.; University Medical Center Schleswig-Holstein (UK-SH), Campus Kiel, Kiel, Germany.
Frieboes HB; Department of Bioengineering, University of Louisville, Lutz Hall 419, Louisville, KY, 40292, USA. .; Center for Predictive Medicine, University of Louisville, Louisville, KY, USA. .; James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA. .
Pokaż więcej
Źródło :
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2021 May; Vol. 70 (5), pp. 1475-1488. Date of Electronic Publication: 2020 Nov 12.
Typ publikacji :
Journal Article
MeSH Terms :
Models, Immunological*
Immunotherapy/*methods
Liver Neoplasms/*immunology
Macrophages/*immunology
Th1 Cells/*immunology
Th2 Cells/*immunology
Cell Communication ; Cell Differentiation ; Cytokines/metabolism ; Cytotoxicity, Immunologic ; Humans ; Liver Neoplasms/therapy ; Lymphocyte Activation ; Neoplasm Metastasis ; Th1-Th2 Balance ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Time-dependent heterogeneity leads to transient suppression of the COVID-19 epidemic, not herd immunity.
Autorzy :
Tkachenko AV; Center for Functional Nanomaterials, Brookhaven National Laboratory, Upton, NY 11973; .
Maslov S; Department of Physics, University of Illinois at Urbana-Champaign, Urbana, IL 61801; .; Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801.; Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
Elbanna A; Department of Civil Engineering, University of Illinois at Urbana-Champaign, Urbana, IL 61801.; Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
Wong GN; Department of Physics, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
Weiner ZJ; Department of Physics, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
Goldenfeld N; Department of Physics, University of Illinois at Urbana-Champaign, Urbana, IL 61801.; Carl R. Woese Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, IL 61801.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Apr 27; Vol. 118 (17).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/immunology
COVID-19*/transmission
Epidemics*
Immunity, Herd*
Models, Immunological*
SARS-CoV-2/*immunology
Humans ; United States/epidemiology
Czasopismo naukowe
Tytuł :
Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers.
Autorzy :
Buckner JH; Graduate Group in Ecology, University of California, Davis, CA 95616; .
Chowell G; Department of Population Health Sciences, School of Public Health, Georgia State University, Atlanta, GA 30303.
Springborn MR; Department of Environmental Science and Policy, University of California, Davis, CA 95616 .
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2021 Apr 20; Vol. 118 (16).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Health Personnel*
Physical Distancing*
COVID-19/*immunology
COVID-19 Vaccines/*immunology
Adult ; Aged ; COVID-19/epidemiology ; Humans ; Middle Aged ; Models, Immunological ; Vaccination
Czasopismo naukowe
Tytuł :
Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
Autorzy :
Rébillard RM; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Charabati M; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Grasmuck C; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Filali-Mouhim A; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Tastet O; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Brassard N; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Daigneault A; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Bourbonnière L; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Anand SP; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
Balthazard R; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Beaudoin-Bussières G; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Microbiology, Infectious Diseases and Immunology, and.
Gasser R; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Microbiology, Infectious Diseases and Immunology, and.
Benlarbi M; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Microbiology, Infectious Diseases and Immunology, and.
Moratalla AC; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Solorio YC; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Boutin M; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Microbiology, Infectious Diseases and Immunology, and.
Farzam-Kia N; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Descôteaux-Dinelle J; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Microbiology, Infectious Diseases and Immunology, and.
Fournier AP; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Gowing E; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Laumaea A; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Microbiology, Infectious Diseases and Immunology, and.
Jamann H; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Lahav B; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Goyette G; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Lemaître F; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Mamane VH; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Prévost J; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Microbiology, Infectious Diseases and Immunology, and.
Richard J; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Microbiology, Infectious Diseases and Immunology, and.
Thai K; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Cailhier JF; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.
Chomont N; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Microbiology, Infectious Diseases and Immunology, and.
Finzi A; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.; Department of Microbiology, Infectious Diseases and Immunology, and.
Chassé M; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.
Durand M; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.
Arbour N; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Kaufmann DE; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.; Department of Medicine, Université de Montréal, Montreal, Quebec, Canada.
Prat A; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Larochelle C; Department of Neuroscience, Université de Montréal, Montreal, Quebec, Canada.; Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montreal, Quebec, Canada.
Pokaż więcej
Źródło :
The Journal of clinical investigation [J Clin Invest] 2021 Apr 15; Vol. 131 (8).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
SARS-CoV-2*/immunology
COVID-19/*immunology
Leukocytes/*classification
Leukocytes/*immunology
Acute Disease ; Adult ; Aged ; B-Lymphocyte Subsets/immunology ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; COVID-19/epidemiology ; COVID-19/mortality ; Case-Control Studies ; Cohort Studies ; Female ; Hospitalization ; Humans ; Lymphocyte Activation ; Male ; Middle Aged ; Models, Immunological ; Monocytes/immunology ; Multivariate Analysis ; Neutrophils/immunology ; Pandemics ; Prognosis ; Prospective Studies ; Quebec/epidemiology ; Risk Factors ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Epithelial response to IFN-γ promotes SARS-CoV-2 infection.
Autorzy :
Heuberger J; Department of Hepatology and Gastroenterology, Charité University Medicine, Berlin, Germany.; Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Trimpert J; Institute of Virology, Freie Universität Berlin, Berlin, Germany.
Vladimirova D; Institute of Virology, Freie Universität Berlin, Berlin, Germany.
Goosmann C; Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.
Lin M; Department of Hepatology and Gastroenterology, Charité University Medicine, Berlin, Germany.
Schmuck R; Department of Surgery, Charité University Medicine, Berlin, Germany.
Mollenkopf HJ; Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.
Brinkmann V; Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.
Tacke F; Department of Hepatology and Gastroenterology, Charité University Medicine, Berlin, Germany.
Osterrieder N; Institute of Virology, Freie Universität Berlin, Berlin, Germany.; Department of Infectious Disease and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong.
Sigal M; Department of Hepatology and Gastroenterology, Charité University Medicine, Berlin, Germany.; Department of Molecular Biology, Max Planck Institute for Infection Biology, Berlin, Germany.; Berlin Institute for Medical Systems Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany.
Pokaż więcej
Źródło :
EMBO molecular medicine [EMBO Mol Med] 2021 Apr 09; Vol. 13 (4), pp. e13191. Date of Electronic Publication: 2021 Mar 03.
Typ publikacji :
Journal Article
MeSH Terms :
Models, Immunological*
SARS-CoV-2*/genetics
SARS-CoV-2*/immunology
SARS-CoV-2*/pathogenicity
COVID-19/*etiology
Interferon-gamma/*immunology
Angiotensin-Converting Enzyme 2/genetics ; Angiotensin-Converting Enzyme 2/metabolism ; Animals ; COVID-19/immunology ; COVID-19/pathology ; Cell Differentiation/immunology ; Colon/immunology ; Colon/pathology ; Colon/virology ; Disease Susceptibility ; Enterocytes/metabolism ; Enterocytes/pathology ; Enterocytes/virology ; Gene Expression ; Host Microbial Interactions/immunology ; Humans ; Interferon-gamma/administration & dosage ; Intestinal Mucosa/immunology ; Intestinal Mucosa/pathology ; Intestinal Mucosa/virology ; Mice ; Organoids/immunology ; Organoids/pathology ; Organoids/virology ; Virus Replication/immunology
Czasopismo naukowe
Tytuł :
SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.
Autorzy :
Casadevall A; Department of Molecular Microbiology and Immunology, Johns Hopkins School of Public Health, Baltimore, Maryland, USA.
Henderson JP; Departments of Medicine and Molecular Microbiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA.
Joyner MJ; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Pirofski LA; Departments of Medicine and Microbiology and Immunology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York, USA.
Pokaż więcej
Źródło :
The Journal of clinical investigation [J Clin Invest] 2021 Apr 01; Vol. 131 (7).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
COVID-19/*therapy
COVID-19/*virology
SARS-CoV-2/*immunology
Antibodies, Neutralizing/biosynthesis ; Antibodies, Neutralizing/blood ; Antibodies, Viral/biosynthesis ; Antibodies, Viral/blood ; COVID-19/immunology ; Genome, Viral ; Host Microbial Interactions/immunology ; Humans ; Immune Evasion ; Immunization, Passive/adverse effects ; Models, Immunological ; Pandemics ; SARS-CoV-2/genetics ; SARS-CoV-2/pathogenicity
SCR Protocol :
COVID-19 serotherapy
Czasopismo naukowe
Tytuł :
Fractional Dynamics of HIV with Source Term for the Supply of New CD4 T-Cells Depending on the Viral Load via Caputo-Fabrizio Derivative.
Autorzy :
Shah Z; Department of Mathematics, University of Lakki Marwat, Lakki Marwat 28420, Pakistan.; Center of Excellence in Theoretical and Computational Science (TaCS-CoE), Faculty of Science, King Mongkut's, University of Technology Thonburi (KMUTT), 126 Pracha Uthit Rd., Bang Mod, Thung Khru, Bangkok 10140, Thailand.
Jan R; School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an 710049, China.
Kumam P; Center of Excellence in Theoretical and Computational Science (TaCS-CoE), Faculty of Science, King Mongkut's, University of Technology Thonburi (KMUTT), 126 Pracha Uthit Rd., Bang Mod, Thung Khru, Bangkok 10140, Thailand.; KMUTT Fixed Point Research Laboratory, KMUTT-Fixed Point Theory and Applications Research Group, SCL 802 Fixed Point Laboratory, Department of Mathematics, Faculty of Science, King Mongkut's, University of Technology Thonburi (KMUTT), 126 Pracha Uthit Rd., Bang Mod, Thung Khru, Bangkok 10140, Thailand.; Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 40402, Taiwan.
Deebani W; Department of Mathematics, College of Science & Arts, King Abdulaziz University, P.O. Box 344, Rabigh 21911, Saudi Arabia.
Shutaywi M; Department of Mathematics, College of Science & Arts, King Abdulaziz University, P.O. Box 344, Rabigh 21911, Saudi Arabia.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2021 Mar 23; Vol. 26 (6). Date of Electronic Publication: 2021 Mar 23.
Typ publikacji :
Journal Article
MeSH Terms :
Models, Immunological*
Viral Load*
CD4-Positive T-Lymphocytes/*immunology
HIV Infections/*immunology
HIV-1/*physiology
Virus Replication/*physiology
Humans
Czasopismo naukowe
Tytuł :
Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.
Autorzy :
Esteve-Sole A; Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu (HSJD), Barcelona, Spain.; Clinical Immunology Unit, HSJD-Hospital Clínic de Barcelona (HCB), Barcelona, Spain.; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Anton J; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Pediatric Rheumatology Department and.
Pino-Ramirez RM; Pediatrics Department, HSJD, Barcelona, Spain.
Sanchez-Manubens J; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Pediatric Rheumatology Department and.; Pediatric Rheumatology Department, Hospital Parc Tauli, Sabadell, Spain.
Fumadó V; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Infectious Diseases Department, HSJD, Barcelona, Spain.
Fortuny C; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Infectious Diseases Department, HSJD, Barcelona, Spain.; CIBER of Epidemiology and Public Health, Madrid, Spain.; Translational Research Network in Paediatric Infectious Diseases (RITIP), Madrid, Spain.
Rios-Barnes M; Infectious Diseases Department, HSJD, Barcelona, Spain.
Sanchez-de-Toledo J; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Cardiology Department, HSJD, Barcelona, Spain.; Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Girona-Alarcón M; Pediatric Intensive Care Unit, and.
Mosquera JM; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Pediatric Rheumatology Department and.
Ricart S; Universitat de Barcelona, Barcelona, Spain.; Pediatrics Department, HSJD, Barcelona, Spain.
Launes C; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Pediatrics Department, HSJD, Barcelona, Spain.; CIBER of Epidemiology and Public Health, Madrid, Spain.
de Sevilla MF; Pediatrics Department, HSJD, Barcelona, Spain.; CIBER of Epidemiology and Public Health, Madrid, Spain.
Jou C; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Pathology Department and Biobank, HSJD, Barcelona, Spain.; Center for the Biomedical Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain.
Muñoz-Almagro C; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; CIBER of Epidemiology and Public Health, Madrid, Spain.; Department of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain.; Molecular Microbiology Department, HSJD, Barcelona, Spain.
González-Roca E; Molecular Biology Core, and.; Department of Immunology, El Centro de Diagnóstico Biomédico (CDB), HCB-IDIBAPS, Barcelona, Spain.
Vergara A; Molecular Biology Core, and.; Microbiology Department, CDB, HCB, Barcelona, Spain.
Carrillo J; IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Badalona, Catalonia, Spain.
Juan M; Clinical Immunology Unit, HSJD-Hospital Clínic de Barcelona (HCB), Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Department of Immunology, El Centro de Diagnóstico Biomédico (CDB), HCB-IDIBAPS, Barcelona, Spain.
Cuadras D; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Statistical Department, Fundació Sant Joan de Déu, Barcelona, Spain.
Noguera-Julian A; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; Infectious Diseases Department, HSJD, Barcelona, Spain.; CIBER of Epidemiology and Public Health, Madrid, Spain.; Translational Research Network in Paediatric Infectious Diseases (RITIP), Madrid, Spain.
Jordan I; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.; CIBER of Epidemiology and Public Health, Madrid, Spain.; Pediatric Intensive Care Unit, and.
Alsina L; Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu (HSJD), Barcelona, Spain.; Clinical Immunology Unit, HSJD-Hospital Clínic de Barcelona (HCB), Barcelona, Spain.; Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło :
The Journal of clinical investigation [J Clin Invest] 2021 Mar 15; Vol. 131 (6).
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*etiology
Cytokines/*blood
Mucocutaneous Lymph Node Syndrome/*etiology
Systemic Inflammatory Response Syndrome/*etiology
Adolescent ; Antibodies, Viral/blood ; Antigen-Antibody Complex/blood ; Antigens, Viral/blood ; COVID-19/immunology ; COVID-19/virology ; Case-Control Studies ; Child ; Child, Preschool ; Cohort Studies ; Cross-Sectional Studies ; Female ; Humans ; Infant ; Interferon-gamma/blood ; Male ; Models, Immunological ; Mucocutaneous Lymph Node Syndrome/immunology ; Pandemics ; SARS-CoV-2/genetics ; SARS-CoV-2/immunology ; Systemic Inflammatory Response Syndrome/immunology ; Systemic Inflammatory Response Syndrome/virology
SCR Disease Name :
pediatric multisystem inflammatory disease, COVID-19 related
Czasopismo naukowe
Tytuł :
A promiscuous interaction of SARS-CoV-2 with bacterial products.
Autorzy :
Carissimo G; A*STAR Infectious Disease laboratories (A*ID Labs), Agency for Science, Technology and Research, Immunos, Singapore 138648, Singapore.; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research, Immunos, Singapore 138648, Singapore.
Ng LFP; A*STAR Infectious Disease laboratories (A*ID Labs), Agency for Science, Technology and Research, Immunos, Singapore 138648, Singapore.; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research, Immunos, Singapore 138648, Singapore.; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool L7 3EA, UK.
Pokaż więcej
Źródło :
Journal of molecular cell biology [J Mol Cell Biol] 2021 Mar 10; Vol. 12 (12), pp. 914-915.
Typ publikacji :
Journal Article
MeSH Terms :
SARS-CoV-2*/immunology
COVID-19/*complications
COVID-19/immunology ; Cytokine Release Syndrome/etiology ; Cytokine Release Syndrome/immunology ; Gram-Negative Bacterial Infections/complications ; Gram-Negative Bacterial Infections/immunology ; Humans ; Lipopolysaccharides/chemistry ; Lipopolysaccharides/immunology ; Models, Immunological ; Risk Factors ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/immunology
Czasopismo naukowe
Tytuł :
SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity.
Autorzy :
Petruk G; Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, SE-22184 Lund, Sweden.
Puthia M; Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, SE-22184 Lund, Sweden.
Petrlova J; Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, SE-22184 Lund, Sweden.
Samsudin F; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore 138671, Singapore.
Strömdahl AC; Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, SE-22184 Lund, Sweden.
Cerps S; Unit of Respiratory Immunopharmacology, Department of Experimental Medicine, Lund University, SE-22184 Lund, Sweden.
Uller L; Unit of Respiratory Immunopharmacology, Department of Experimental Medicine, Lund University, SE-22184 Lund, Sweden.
Kjellström S; Division of Mass Spectrometry, Department of Clinical Sciences, Lund University, SE-22184 Lund, Sweden.
Bond PJ; Bioinformatics Institute (BII), Agency for Science, Technology and Research (A*STAR), Singapore 138671, Singapore.; Department of Biological Sciences, National University of Singapore, Singapore 117543, Singapore.
Schmidtchen AA; Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, SE-22184 Lund, Sweden.; Copenhagen Wound Healing Center, Bispebjerg Hospital, Department of Biomedical Sciences, University of Copenhagen, DK-2400 Copenhagen, Denmark.; Dermatology, Skåne University Hospital, SE-22185 Lund, Sweden.
Pokaż więcej
Źródło :
Journal of molecular cell biology [J Mol Cell Biol] 2021 Mar 10; Vol. 12 (12), pp. 916-932.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
SARS-CoV-2*/immunology
SARS-CoV-2*/pathogenicity
SARS-CoV-2*/physiology
COVID-19/*complications
Inflammation/*etiology
Lipopolysaccharides/*metabolism
Spike Glycoprotein, Coronavirus/*metabolism
Animals ; Binding Sites ; COVID-19/immunology ; COVID-19/virology ; Cytokine Release Syndrome/etiology ; Cytokine Release Syndrome/immunology ; Disease Models, Animal ; Gram-Negative Bacterial Infections/complications ; Gram-Negative Bacterial Infections/immunology ; Humans ; In Vitro Techniques ; Lipid A/chemistry ; Lipid A/immunology ; Lipid A/metabolism ; Lipopolysaccharides/chemistry ; Lipopolysaccharides/immunology ; Mice ; Mice, Inbred BALB C ; Mice, Transgenic ; Models, Immunological ; Models, Molecular ; Molecular Docking Simulation ; Protein Binding ; Protein Interaction Domains and Motifs ; Respiratory Distress Syndrome/etiology ; Risk Factors ; Spike Glycoprotein, Coronavirus/chemistry ; Spike Glycoprotein, Coronavirus/immunology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies